ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643735 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643735; 2) Community: the network communities that were significantly associated with the response to NSC 643735; 3) Molecule: the relationships between components within communities and NSC 643735; 4) MDR: the compounds that were significantly associated with the NSC 643735.

NSC Compound Enrichment Correlation
NSC 684480 7H-Pyrido[3,2-d][1]benzazepin-6-one, 2-(3-chlorophenyl)- 5,6-dihydro-4-phenyl- 0.0133986477026051 -0.24168779
NSC 709341 Null 0.0133986477026051 0.36100617
NSC 712735 Null 0.0133986477026051 -0.055182749
NSC 741078 Selumetinib 0.0133986477026051 0.22695086
NSC 170983 R 5147 0.0133986477026052 0.036968325
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0133986477026052 0.041801862
NSC 328410 Camptothecin Derivative 0.013789112253851 0.1176509
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.013789112253851 0.62100196
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.013789112253851 0.34336961
NSC 668264 Null 0.013789112253851 0.069272308
Total:73  Current:25    [First] [Prev] [Next] [Last]